Oncology & Cancer

Low-dose sorafenib may improve therapy for head and neck cancer

Adding low doses of the targeted agent sorafenib to the chemotherapy and radiation now often used to treat head and neck cancer might significantly improve patient care and quality of life, according to a new study by researchers ...

Oncology & Cancer

FATE results prove to be useful in end-of-life care

Though there have been significant improvements in the treatment of head and neck cancer, there is still a lack of data on the experience of end of life care for head and neck cancer patients, according to a new study published ...

Oncology & Cancer

Head and neck cancer -- what you need to know

It is estimated that 40,000 men and women in the United States will develop head and neck cancer in the coming year. Head and neck cancer involves the cells that line the mucosal surfaces or moist tissue lining in the head ...

page 18 from 19